Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 817.65M | 671.91M | 537.30M | 421.12M | 411.85M | 326.50M |
Gross Profit | 48.09M | 41.32M | 43.32M | 29.61M | -29.57M | 7.27M |
EBITDA | 26.64M | 24.70M | 24.90M | 18.07M | -31.62M | 250.00K |
Net Income | 6.17M | 3.70M | 9.82M | 4.37M | -46.35M | -13.72M |
Balance Sheet | ||||||
Total Assets | 337.55M | 344.47M | 234.24M | 214.98M | 217.79M | 199.64M |
Cash, Cash Equivalents and Short-Term Investments | 59.19M | 45.63M | 45.58M | 25.36M | 38.76M | 48.63M |
Total Debt | 36.09M | 25.00M | 20.37M | 8.19M | 8.42M | 4.20M |
Total Liabilities | 202.15M | 213.65M | 107.12M | 97.68M | 104.86M | 40.35M |
Stockholders Equity | 135.40M | 130.82M | 127.13M | 117.30M | 112.94M | 159.29M |
Cash Flow | ||||||
Free Cash Flow | -11.20M | -2.97M | 16.40M | -19.11M | -8.53M | -4.65M |
Operating Cash Flow | 45.27M | 25.59M | 25.72M | 1.59M | 3.92M | 10.62M |
Investing Cash Flow | -54.77M | -27.13M | -6.43M | -9.82M | -8.92M | -14.62M |
Financing Cash Flow | 13.80M | 1.58M | 935.00K | -5.16M | -4.87M | -2.94M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
82 Outperform | HK$9.31B | 9.45 | 23.28% | 5.28% | 12.70% | 9.91% | |
71 Outperform | $10.01B | 7.76 | 4.75% | 3.86% | 4.24% | 25.30% | |
70 Outperform | $16.83B | 8.27 | 16.66% | 5.45% | -8.19% | -9.98% | |
67 Neutral | HK$102.71M | 23.19 | 3.32% | ― | 58.64% | 106.25% | |
58 Neutral | HK$14.15B | 4.41 | -3.01% | 7.30% | 3.67% | -54.16% | |
54 Neutral | HK$251.03M | 30.00 | -5.30% | ― | -72.42% | -1037.50% | |
49 Neutral | HK$499.02M | ― | -2.14% | 0.67% | 1.66% | -51.60% |